Fasoracetam vs Pramiracetam

Mechanism

Non-classical racetam that modulates all three groups of metabotropic glutamate receptors (mGluR Groups I, II, and III) and upregulates GABA-B receptors — a unique mechanism that distinguishes it from other racetams. Also enhances high-affinity choline uptake (HACU) and stimulates acetylcholine release. Does not significantly affect adrenergic, serotonergic, or dopaminergic receptors. The GABA-B upregulation is particularly notable as it may counteract GABA-B receptor downregulation caused by phenibut or baclofen tolerance.

Standard Dosing

20-100 mg 1-3 times daily (sublingual or oral)

Timing

Morning and afternoon. Sublingual administration may provide faster onset and higher bioavailability. With or without food.

Cycle Duration

Cycles of 4-8 weeks on, 2-4 weeks off. Limited long-term safety data.

Side Effects

• Headache
• Fatigue
• GI discomfort
• Irritability
• Brain fog (paradoxical, at excessive doses)

Contraindications

• Known hypersensitivity to racetams
• Pregnancy and lactation (no safety data)
• Severe renal or hepatic impairment

Best Stacking Partners

Mechanism

Potently stimulates high-affinity choline uptake (HACU) in hippocampal synaptosomes, the rate-limiting step in acetylcholine synthesis. This profoundly enhances cholinergic neurotransmission without direct receptor agonism. Approximately 10-30x more potent than piracetam on a per-milligram basis. Does not significantly affect other neurotransmitter systems, making it a highly targeted cholinergic enhancer.

Standard Dosing

400-1200 mg/day divided into 2-3 doses

Timing

With fat-containing meals (fat-soluble). Morning and early afternoon dosing preferred.

Cycle Duration

Cycles of 8-12 weeks on, 4 weeks off

Side Effects

• Headache
• GI discomfort
• Emotional blunting reported by some users
• Irritability

Contraindications

• Severe renal impairment
• Known hypersensitivity to racetams

Best Stacking Partners